Fat Science Ozempic, Mounjaro, and Wegovy, Oh My! Understanding Metabolic Medicines
Dr. Emily Cooper, Andrea Taylor, and Mark Wright discuss the exciting world of metabolic medicines in this episode, exploring the history and development of GLP-1 mimetics (medications that mimic the body's GLP -1 hormone) and their positive impacts on metabolic health.
From the challenges of approval to insurance coverage, they delve into the complexities of these drugs and the need for individualized treatment. Sharing personal experiences and insights, they challenge the notion of these medications as weight loss miracles while emphasizing the importance of addressing the underlying issues of metabolic dysfunction.
This episode will open your eyes to the groundbreaking progress being made in metabolic science and leave you excited for the future of these medications.
Resources from the episode:
- Learn more about Fat Science here.
- Connect with Dr. Emily Cooper on LinkedIn.
- Connect with Andrea Taylor on LinkedIn.
- Connect with Mark Wright on LinkedIn.
Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go (and stay!) away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.
If you have a show idea, feedback, or just want to connect, email Mark Wright at mark@beatsworking.show.